XML 69 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 8 - Income Taxes
12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]

8.  Income Taxes


   

Year Ended December 31,

 
   

2014

   

2013

   

2012

 
   

(In thousands)

 

U.S.

                       

Current

  $ 3,032     $ 719     $ 271  

Deferred

    2,882       5,432       (19,863

)

Foreign

                       

Current

    476       291       512  

Withholding

    3,103       3,830       948  

Deferred

    4       108       (197

)

Total provision (benefit)

  $ 9,497     $ 10,380     $ (18,329

)


During the years ended December 31, 2014, 2013 and 2012, income before taxes from U.S. operations was $26.2 million, $29.6 million and $17.7 million, respectively, and income before taxes from foreign operations was $1.8 million, $1.7 million and $1.2 million, respectively.


The income tax provision (benefit) differs from the amount estimated by applying the statutory federal income tax rate (35%) for the following reasons (in thousands):


   

Year Ended December 31,

 
   

2014

   

2013

   

2012

 

Federal statutory tax provision

  $ 9,786     $ 10,958     $ 6,609  

State tax provision (benefit)

    56       581       (925 )

Stock compensation expense

    540       393       644  

Tax credits

    (3,924 )     (5,424

)

    (722

)

Foreign tax, net

    3,170       3,884       906  

Change in valuation allowance

                (25,223

)

Other

    (131

)

    (12

)

    382  

Tax provision (benefit)

  $ 9,497     $ 10,380     $ (18,329 )

As of December 31, 2014, the Company had California net operating loss carry-forwards (“NOLs”) of approximately $6.2 million. The California NOLs begin expiring after 2031.


The Company’s 2012 tax provision did not include the benefit of the 2012 federal R&D credit. On January 2, 2013, the President of the United States signed into law The American Taxpayer Relief Act of 2012. Under prior U.S. law, a taxpayer was entitled to a research tax credit for qualifying amounts paid or incurred on or before December 31, 2011. The 2012 Taxpayer Relief Act extended the research tax credit for two years to December 31, 2013. The extension of the research tax credit was retroactive to January 1, 2012 and included amounts paid or incurred after December 31, 2011. As of December 31, 2014, the Company had federal and state research and experimental and other tax credit (“R&D credits”) carry-forwards of approximately $9.2 million and $12.4 million, respectively. The federal credits begin to expire after 2025, while the California credits have no expiration. The extent to which the federal and state credit carry forwards can be used to offset future tax liabilities, respectively, may be limited, depending on the extent of ownership changes within any three-year period as provided in the Tax Reform Act of 1986 and the California Conformity Act of 1987.  


The Company assesses its deferred tax assets for recoverability on a regular basis, and where applicable, a valuation allowance is recorded to reduce the total deferred tax asset to an amount that will, more likely than not, be realized in the future. In fiscal year 2008, management concluded that it was more likely than not that the Company’s net deferred tax assets would not be fully realizable. As a result of management’s evaluation, the Company recorded valuation allowances against substantially all of its net deferred tax assets at that time. The Company evaluates positive and negative evidence at each financial reporting period to determine whether it is more likely than not that the Company’s deferred tax assets would be realizable.  In accordance with such process, at December 31, 2012, the Company again evaluated the available objective evidence, both positive and negative, and concluded that it was more likely than not at that time that a portion of its deferred tax assets would be realizable, and accordingly, the Company determined that valuation allowances aggregating to $19.9 million were no longer needed. This amount released from the valuation allowance has been reported as a component of income tax benefit in the accompanying Consolidated Statement of Operations for the year ended December 31, 2012. The remaining balance of the valuation allowance primarily relates to California R&D tax credits that have not met the “more-likely-than-not” realization threshold criteria. Under current tax law, the Company on an annual basis generates more California credits than California tax. As a result, at December 31, 2014 and 2013, the excess credits of $5.4 million and $5.1 million, respectively continued to be subject to a full valuation allowance. The Company will continue to review its deferred tax assets in accordance with the applicable accounting standards. Net deferred tax assets balance as of December 31, 2014 and 2013 was $11.3 million and $14.5 million respectively. The balance as of December 31, 2014 consists of $3.3 million net deferred tax assets-current portion and $8.0 million net deferred tax assets-long-term portion. The balance as of December 31, 2013 consists of $5.9 million net deferred tax assets-current portion and $8.6 million net deferred tax assets-long-term portion.


Tax attributes related to stock option windfall deductions are not recorded until they result in a reduction of cash tax payable. Federal tax credits and state net operating losses from windfall deductions were excluded from the deferred tax asset balance as of December 31, 2014. As of December 31, 2014, the benefit of the federal credits and state net operating loss deferred tax assets of $5.1 million and $66,000, respectively, will be recorded to additional paid-in capital when they reduce cash taxes payable. As of December 31, 2013, the excluded windfall deductions for federal and state purposes were $4.9 million and $78,000, respectively.


The components of the net deferred tax assets are comprised of (in thousands):


   

December 31,

 
   

2014

   

2013

 

Deferred tax Assets

               
                 

Net operating loss carry forward

  $ 533     $ 621  

Research and development and other credit carry forward

    5,438       6,938  

Foreign tax credit carry forward

    1        

Accruals deductible in different periods

    3,021       3,931  

Intangible assets

    5,555       6,105  

Stock-based compensation

    2,861       2,491  

Valuation allowance

    (5,433

)

    (5,087

)

Subtotal

  $ 11,976     $ 14,999  
                 

Deferred tax liabilities

               
                 

Fixed assets

    (632

)

    (478

)

Net Deferred tax assets

  $ 11,344     $ 14,521  

In accordance with the provisions of the accounting standard relating to accounting for uncertain tax positions, the Company classifies its liabilities for income tax exposures as long-term. The Company includes interest and penalties related to unrecognized tax benefits within the Company’s income tax provision. As of December 31, 2014 and 2013, the Company had accrued interest and penalties related to unrecognized tax benefits of $467,000 and $466,000, respectively.  In the years ended December 31, 2014, 2013 and 2012, the Company recognized charges (credits) for interest and penalties related to unrecognized tax benefits in the consolidated statements of operations of $1,000, $39,000 and $(16,000), respectively.


The Company’s total amount of unrecognized tax benefits, excluding interest and penalties, as of December 31, 2014 was $10.4 million, of which $6.3 million, if recognized, would affect the Company’s effective tax rate. The Company’s total amount of unrecognized tax benefits, excluding interest and penalties, as of December 31, 2013 was $10.2 million, of which $6.3 million, if recognized, would affect the Company's effective tax rate. As of December 31, 2014, the Company has recorded unrecognized tax benefits of $2.6 million, including interest and penalties, as long-term income taxes payable in its consolidated balance sheet. The remaining $8.3 million has been recorded net of our deferred tax assets, of which $4.1 million is subject to a full valuation allowance. The Company does not expect the change in unrecognized tax benefits over the next twelve months to materially impact its results of operations and financial position.


The Company conducts business globally and, as a result, files numerous consolidated and separate income tax returns in the U.S. federal, various state and foreign jurisdictions. Because the Company used some of the tax attributes carried forward from previous years to tax years that are still open, statutes of limitation remain open for all tax years to the extent of the attributes carried forward into tax year 2002 for federal and California tax purposes. The Company’s France income tax examinations for 2009 were closed during the fiscal year of 2012 with immaterial adjustments.  The Company is not subject to income tax examinations in any other of its major foreign subsidiaries’ jurisdictions.


A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):


   

Amount

 

Gross unrecognized tax benefits, January 1, 2012

  $ 9,644  

Increases in tax positions for current year

    616  

Increase in tax positions for prior years

     

Lapse in statute of limitations

    (707

)

Gross unrecognized tax benefits, December 31, 2012

    9,553  

Increases in tax positions for current year

    1,052  

Increases in tax positions for prior years

     

Lapse in statute of limitations

    (389

)

Gross unrecognized tax benefits, December 31, 2013

    10,216  

Increases in tax positions for current year

    809  

Increases in tax positions for prior years

     

Lapse in statute of limitations

    (597

)

Gross unrecognized tax benefits, December 31, 2014

  $ 10,428  

Undistributed earnings of the Company’s foreign subsidiaries of $4.8 million are considered to be indefinitely reinvested and accordingly, no provision for federal and state income taxes has been provided thereon. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable at this time.


Valuation allowance for deferred tax assets is summarized:


   

Balance at

Beginning

of Period

   

Charged

to Costs

and Expenses

   

Deductions/

Write-offs

of Accounts

   

Balance

at End

of Period

 

Valuation allowance for deferred tax assets

                               

2014

  $ 5,087     $ 346     $     $ 5,433  

2013

    4,708       379             5,087  

2012

    30,731             (26,023

)

    4,708